How Much Aspirin?

Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.

Facebook Linkedin Weibo

Thromb Haemost 1990; 64(03): 486
DOI: 10.1055/s-0038-1647342

Letter to the Editor

Schattauer GmbH Stuttgart

J R O’Brien

The Haematology Research Laboratories St. Mary’s Hospital Portsmouth, Hants., PO3 6AG, U. K.

,

M D Ethwrington

The Haematology Research Laboratories St. Mary’s Hospital Portsmouth, Hants., PO3 6AG, U. K.

Weitere Informationen

Publikationsverlauf

Received 06. April 1990

Accepted after revision 25. Juni 1990

Publikationsdatum:
25. Juli 2018 (online)

References
1 Antiplatelet Tiialists Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J 1988 296. 316-319

MissingFormLabel
PubMed Suche in Google Scholar
2 Reilly IA G, Fitzgerald GA. Inhibition of Thromboxane formation in vivo and ex vivo: implication for therapy with platelet inhibitory drugs.. Blood 1987; 69: 180-186

MissingFormLabel
PubMed Suche in Google Scholar
3 Toivanen J, Ylikorkala O, Viinikka L. One milligramme of acetylsalicylic acid daily inhibits platelet thromboxane A₂ production. Thromb Res 1984; 35: 681-687

MissingFormLabel
Crossref PubMed Suche in Google Scholar